Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations (Unaudited)

v3.19.2
Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2019
Jun. 30, 2018
Operating Expenses:        
Research and development $ 154 $ 3,251 $ 988 $ 6,724
Selling, general and administrative 2,125 1,906 5,347 5,593
Total operating expenses 2,279 5,157 6,335 12,317
Loss from Operations (2,279) (5,157) (6,335) (12,317)
Other income (expense)        
Loss on disposal of assets (31) 0 (31) 0
Interest expense (479) (3,924) (933) (6,855)
Total Other Income (Expense) (510) (3,924) (964) (6,855)
Loss before provision for income taxes (2,789) (9,081) (7,299) (19,172)
Provision for income taxes 0 0 0 0
Net loss $ (2,789) $ (9,081) $ (7,299) $ (19,172)
Net loss per common share - basic and diluted $ (.05) $ (0.18) $ (.14) $ (0.38)
Weighted average common shares outstanding - basic and diluted 51,918,252 50,117,977 51,507,849 50,117,977